Literature DB >> 8709973

Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.

D Senthil1, K Subha, N Saravanan, P Varalakshmi.   

Abstract

Calcium oxalate crystal growth and aggregation leads to the formation of renal calculi. It is known to be inhibited by several compounds both in vitro and in vivo conditions. The present study highlights the inhibitory potential of sodium pentosan polysulphate (SPP), a semi-synthetic glycosaminoglycan (GAG) on calcium oxalate crystal growth in vitro. Its efficacy was compared with those of known inhibitors like pyrophosphate, heparin and chondroitin-4-sulphate. Of the above compounds pyrophosphate was found to be the most potent inhibitor. Among the GAGs, SPP exhibited 80% inhibitory activity as compared to heparin. A lesser degree of inhibition was observed with chondroitin-4-sulphate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709973     DOI: 10.1007/BF00239316

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Modified methods for the estimation of urine calcium.

Authors:  J HOOPER
Journal:  J Med Lab Technol       Date:  1956-07

2.  A quantitative investigation of the effects on the growth of calcium oxalate crystals on potential inhibitors.

Authors:  S G Welshman; M G McGeown
Journal:  Br J Urol       Date:  1972-12

3.  The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis.

Authors:  H Fleisch; S Bisaz
Journal:  Experientia       Date:  1964-05-15

4.  The direct measurement of inhibitory capacity to crystal growth of calcium oxalate in undiluted urine and in other inhibitor containing solutions.

Authors:  J M Baumann; M Wacker
Journal:  Urol Res       Date:  1980

5.  [Observation on urinary glycosaminoglycan excretion in patients with urinary calculus in relation to the nature of organic matrix of calculi].

Authors:  S Baba; K Nakazawa; K Odajima; T Fujioka; H Nakamura
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1983-04

6.  Binding of glycosaminoglycan inhibitors to calcium oxalate crystals in relation to ionic strength.

Authors:  B Fellström; M Lindsjö; B G Danielson; F A Karlsson; S Ljunghall
Journal:  Clin Chim Acta       Date:  1989-04-14       Impact factor: 3.786

7.  Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.

Authors:  K Subha; P Varalakshmi
Journal:  Biochem Mol Biol Int       Date:  1993-02

Review 8.  Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones.

Authors:  E R Boevé; L C Cao; C F Verkoelen; J C Romijn; W C de Bruijn; F H Schröder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate.

Authors:  B Fellström; U Backman; B Danielson; B Wikström
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents.

Authors:  A L Rodgers; J Garside
Journal:  Invest Urol       Date:  1981-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.